Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Mar;111(3):887–893. doi: 10.1111/j.1476-5381.1994.tb14821.x

Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.

A C Kappelle 1, G Biessels 1, B Bravenboer 1, T van Buren 1, J Traber 1, D J de Wildt 1, W H Gispen 1
PMCID: PMC1910095  PMID: 8019766

Abstract

1. Neuropathy is a frequently diagnosed complication of diabetes mellitus. Effective pharmacotherapy is not available. 2. The spontaneously diabetic BB/Wor rats develop secondary complications like neuropathy as do human diabetic patients. 3. BB/Wor rats treated with insulin via a subcutaneous implant show a significant impairment of sensory and motor nerve conduction velocity 6 weeks after the onset of diabetes mellitus. 4. Intraperitoneal treatment of diabetic BB/Wor rats with the Ca2+ antagonist, nimodipine (20 mg kg-1), from week 6 onwards every 48 h for a period of 6 weeks resulted in a significant increase of sensory and motor nerve conduction velocity. 5. Twelve weeks after the onset of diabetes mellitus BB/Wor rats show a 40% impairment of sciatic nerve blood flow as compared to the non-diabetic age-matched controls. Treatment with nimodipine (20 mg kg-1) from week 6 onwards significantly increased the sciatic nerve blood flow as compared to placebo-treated diabetic BB/Wor rats. 6. The adrenergic responsiveness of the vasa nervorum of the sciatic nerve to tyramine and phenylephrine was investigated as a parameter for autonomic neuropathy. 7. The fact that nimodipine treatment restored the reduced response to tyramine independently of the reduced postsynaptic phenylephrine responsiveness indicates that nimodipine improves adrenergic responsiveness mainly at the presynaptic level.

Full text

PDF
887

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Afzal N., Ganguly P. K., Dhalla K. S., Pierce G. N., Singal P. K., Dhalla N. S. Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes. 1988 Jul;37(7):936–942. doi: 10.2337/diab.37.7.936. [DOI] [PubMed] [Google Scholar]
  2. Allen G. S., Ahn H. S., Preziosi T. J., Battye R., Boone S. C., Boone S. C., Chou S. N., Kelly D. L., Weir B. K., Crabbe R. A. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983 Mar 17;308(11):619–624. doi: 10.1056/NEJM198303173081103. [DOI] [PubMed] [Google Scholar]
  3. Amenta F., Mione M. C., Napoleone P. The autonomic innervation of the vasa nervorum. J Neural Transm. 1983;58(3-4):291–297. doi: 10.1007/BF01252814. [DOI] [PubMed] [Google Scholar]
  4. Appenzeller O., Dhital K. K., Cowen T., Burnstock G. The nerves to blood vessels supplying blood to nerves: the innervation of vasa nervorum. Brain Res. 1984 Jun 25;304(2):383–386. doi: 10.1016/0006-8993(84)90344-5. [DOI] [PubMed] [Google Scholar]
  5. Bravenboer B., Kappelle A. C., Hamers F. P., van Buren T., Erkelens D. W., Gispen W. H. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia. 1992 Sep;35(9):813–817. doi: 10.1007/BF00399926. [DOI] [PubMed] [Google Scholar]
  6. Bravenboer B., Kappelle A. C., van Buren T., Erkelens D. W., Gispen W. H. ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats. Acta Diabetol. 1993;30(1):21–24. doi: 10.1007/BF00572869. [DOI] [PubMed] [Google Scholar]
  7. Britland S. T., Young R. J., Sharma A. K., Clarke B. F. Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes. 1990 Aug;39(8):909–913. doi: 10.2337/diab.39.8.909. [DOI] [PubMed] [Google Scholar]
  8. Bär P. R., Renkema G. H., Veraart C. M., Hol E. M., Gispen W. H. Nimodipine protects cultured spinal cord neurones from depolarization-induced inhibition of neurite outgrowth. Cell Calcium. 1993 Apr;14(4):293–299. doi: 10.1016/0143-4160(93)90050-g. [DOI] [PubMed] [Google Scholar]
  9. Bär P. R., Traber J., Schuurman T., Gispen W. H. CNS and PNS effects of nimodipine. J Neural Transm Suppl. 1990;31:55–71. [PubMed] [Google Scholar]
  10. Cameron N. E., Cotter M. A., Low P. A. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol. 1991 Jul;261(1 Pt 1):E1–E8. doi: 10.1152/ajpendo.1991.261.1.E1. [DOI] [PubMed] [Google Scholar]
  11. Cohen A. J., McGill P. D., Rossetti R. G., Guberski D. L., Like A. A. Glomerulopathy in spontaneously diabetic rat. Impact of glycemic control. Diabetes. 1987 Aug;36(8):944–951. doi: 10.2337/diab.36.8.944. [DOI] [PubMed] [Google Scholar]
  12. Crisá L., Mordes J. P., Rossini A. A. Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev. 1992 Apr;8(1):4–37. [PubMed] [Google Scholar]
  13. De Koning P., Gispen W. H. Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides. 1987 May-Jun;8(3):415–422. doi: 10.1016/0196-9781(87)90003-9. [DOI] [PubMed] [Google Scholar]
  14. Dhital K., Lincoln J., Appenzeller O., Burnstock G. Adrenergic innervation of vasa and nervi nervorum of optic, sciatic, vagus and sympathetic nerve trunks in normal and streptozotocin-diabetic rats. Brain Res. 1986 Mar 5;367(1-2):39–44. doi: 10.1016/0006-8993(86)91576-3. [DOI] [PubMed] [Google Scholar]
  15. Dyck P. J., Hansen S., Karnes J., O'Brien P., Yasuda H., Windebank A., Zimmerman B. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2513–2517. doi: 10.1073/pnas.82.8.2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fitzgerald M. E., Caldwell R. B. The retinal microvasculature of spontaneously diabetic BB rats: structure and luminal surface properties. Microvasc Res. 1990 Jan;39(1):15–27. doi: 10.1016/0026-2862(90)90056-w. [DOI] [PubMed] [Google Scholar]
  17. Foy J. M., Lucas P. D. Effect of experimental diabetes, food deprivation and genetic obesity on the sensitivity of pithed rats to autonomic agents. Br J Pharmacol. 1976 Jun;57(2):229–234. doi: 10.1111/j.1476-5381.1976.tb07472.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hamers F. P., van der Hoop R. G., Steerenburg P. A., Neijt J. P., Gispen W. H. Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats. Toxicol Appl Pharmacol. 1991 Dec;111(3):514–522. doi: 10.1016/0041-008x(91)90255-d. [DOI] [PubMed] [Google Scholar]
  19. Haws C. W., Gourley J. K., Heistad D. D. Effects of nimodipine on cerebral blood flow. J Pharmacol Exp Ther. 1983 Apr;225(1):24–28. [PubMed] [Google Scholar]
  20. Hendriksen P. H., Oey P. L., Wieneke G. H., van Huffelen A. C., Gispen W. H. Hypoxic neuropathy versus diabetic neuropathy. An electrophysiological study in rats. J Neurol Sci. 1992 Jul;110(1-2):99–106. doi: 10.1016/0022-510x(92)90015-d. [DOI] [PubMed] [Google Scholar]
  21. Hotta N., Kakuta H., Fukasawa H., Koh N., Sakakibara F., Komori H., Sakamoto N. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats. Diabetes. 1992 May;41(5):587–591. doi: 10.2337/diab.41.5.587. [DOI] [PubMed] [Google Scholar]
  22. Jackson C. V., Carrier G. O. Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):260–265. doi: 10.1097/00005344-198303000-00016. [DOI] [PubMed] [Google Scholar]
  23. Kappelle A. C., Bravenboer B., van Buren T., Traber J., Erkelens D. W., Gispen W. H. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat. Br J Pharmacol. 1993 Mar;108(3):780–785. doi: 10.1111/j.1476-5381.1993.tb12878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Koistinaho J., Wadhwani K. C., Rapoport S. I. Adrenergic innervation in the tibial and vagus nerves of rats with streptozotocin-induced diabetes. Brain Res. 1990 Apr 9;513(1):106–112. doi: 10.1016/0006-8993(90)91095-x. [DOI] [PubMed] [Google Scholar]
  25. Low P. A., Tuck R. R. Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J Physiol. 1984 Feb;347:513–524. doi: 10.1113/jphysiol.1984.sp015079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mayer J. H., Tomlinson D. R. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia. 1983 Nov;25(5):433–438. doi: 10.1007/BF00282524. [DOI] [PubMed] [Google Scholar]
  27. Milner P., Appenzeller O., Qualls C., Burnstock G. Differential vulnerability of neuropeptides in nerves of the vasa nervorum to streptozotocin-induced diabetes. Brain Res. 1992 Mar 6;574(1-2):56–62. doi: 10.1016/0006-8993(92)90799-f. [DOI] [PubMed] [Google Scholar]
  28. Monafo W. W., Eliasson S. G., Shimazaki S., Sugimoto H. Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp Neurol. 1988 Mar;99(3):607–614. doi: 10.1016/0014-4886(88)90177-x. [DOI] [PubMed] [Google Scholar]
  29. Mordes J. P., Desemone J., Rossini A. A. The BB rat. Diabetes Metab Rev. 1987 Jul;3(3):725–750. doi: 10.1002/dmr.5610030307. [DOI] [PubMed] [Google Scholar]
  30. Morff R. J. Microvascular reactivity to norepinephrine at different arteriolar levels and durations of streptozocin-induced diabetes. Diabetes. 1990 Mar;39(3):354–360. doi: 10.2337/diab.39.3.354. [DOI] [PubMed] [Google Scholar]
  31. Robertson S., Cameron N. E., Cotter M. A. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia. 1992 Dec;35(12):1113–1117. doi: 10.1007/BF00401363. [DOI] [PubMed] [Google Scholar]
  32. Scriabine A., van den Kerckhoff W. Pharmacology of nimodipine. A review. Ann N Y Acad Sci. 1988;522:698–706. doi: 10.1111/j.1749-6632.1988.tb33415.x. [DOI] [PubMed] [Google Scholar]
  33. Sima A. A., Bril V., Nathaniel V., McEwen T. A., Brown M. B., Lattimer S. A., Greene D. A. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med. 1988 Sep 1;319(9):548–555. doi: 10.1056/NEJM198809013190905. [DOI] [PubMed] [Google Scholar]
  34. Sima A. A., Prashar A., Zhang W. X., Chakrabarti S., Greene D. A. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. J Clin Invest. 1990 May;85(5):1410–1420. doi: 10.1172/JCI114585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sima A. A., Thibert P. Proximal motor neuropathy in the BB-Wistar rat. Diabetes. 1982 Sep;31(9):784–788. doi: 10.2337/diab.31.9.784. [DOI] [PubMed] [Google Scholar]
  36. Smout A. J., Jebbink H. J., Bravenboer B. Gastrointestinal manifestations of diabetic autonomic neuropathy. Neth J Med. 1991 Dec;39(5-6):329–332. [PubMed] [Google Scholar]
  37. Strowig S., Raskin P. Glycemic control and diabetic complications. Diabetes Care. 1992 Sep;15(9):1126–1140. doi: 10.2337/diacare.15.9.1126. [DOI] [PubMed] [Google Scholar]
  38. Sundqvist T., Oberg P. A., Rapoport S. I. Blood flow in rat sciatic nerve during hypotension. Exp Neurol. 1985 Oct;90(1):139–148. doi: 10.1016/0014-4886(85)90047-0. [DOI] [PubMed] [Google Scholar]
  39. Tomlinson D. R. The pharmacology of diabetic neuropathy. Diabetes Metab Rev. 1992 Apr;8(1):67–84. doi: 10.1002/dmr.5610080107. [DOI] [PubMed] [Google Scholar]
  40. Tuck R. R., Schmelzer J. D., Low P. A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 1984 Sep;107(Pt 3):935–950. doi: 10.1093/brain/107.3.935. [DOI] [PubMed] [Google Scholar]
  41. Van der Zee C. E., Brakkee J. H., Gispen W. H. Putative neurotrophic factors and functional recovery from peripheral nerve damage in the rat. Br J Pharmacol. 1991 May;103(1):1041–1046. doi: 10.1111/j.1476-5381.1991.tb12297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Van der Zee C. E., Schuurman T., van der Hoop R. G., Traber J., Gispen W. H. Beneficial effect of nimodipine on peripheral nerve function in aged rats. Neurobiol Aging. 1990 Jul-Aug;11(4):451–456. doi: 10.1016/0197-4580(90)90012-o. [DOI] [PubMed] [Google Scholar]
  43. Van der Zee C. E., Van den Buuse M., Gispen W. H. Beneficial effect of an ACTH-(4-9) analog on peripheral neuropathy and blood pressure response to tyramine in streptozocin diabetic rats. Eur J Pharmacol. 1990 Feb 27;177(3):211–213. doi: 10.1016/0014-2999(90)90273-9. [DOI] [PubMed] [Google Scholar]
  44. Watkins P. J. Diabetic autonomic neuropathy. N Engl J Med. 1990 Apr 12;322(15):1078–1079. doi: 10.1056/NEJM199004123221511. [DOI] [PubMed] [Google Scholar]
  45. White R. E., Carrier G. O. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J Pharmacol Exp Ther. 1990 Jun;253(3):1057–1062. [PubMed] [Google Scholar]
  46. Yasuda H., Sonobe M., Yamashita M., Terada M., Hatanaka I., Huitian Z., Shigeta Y. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235. Diabetes. 1989 Jul;38(7):832–838. doi: 10.2337/diab.38.7.832. [DOI] [PubMed] [Google Scholar]
  47. Yuan X. Q., Smith T. L., Prough D. S., De Witt D. S., Dusseau J. W., Lynch C. D., Fulton J. M., Hutchins P. M. Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats. Am J Physiol. 1990 May;258(5 Pt 2):H1395–H1401. doi: 10.1152/ajpheart.1990.258.5.H1395. [DOI] [PubMed] [Google Scholar]
  48. Zhang W. X., Chakrabarti S., Greene D. A., Sima A. A. Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variability and vagus nerve structure. Diabetes. 1990 May;39(5):613–618. doi: 10.2337/diab.39.5.613. [DOI] [PubMed] [Google Scholar]
  49. Zochodne D. W., Low P. A. Adrenergic control of nerve blood flow. Exp Neurol. 1990 Sep;109(3):300–307. doi: 10.1016/s0014-4886(05)80021-4. [DOI] [PubMed] [Google Scholar]
  50. van der Zee C. E., Schuurman T., Traber J., Gispen W. H. Oral administration of nimodipine accelerates functional recovery following peripheral nerve damage in the rat. Neurosci Lett. 1987 Dec 16;83(1-2):143–148. doi: 10.1016/0304-3940(87)90231-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES